Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
2.380
-0.170 (-6.67%)
At close: Aug 8, 2025, 4:00 PM
2.460
+0.080 (3.36%)
After-hours: Aug 8, 2025, 7:23 PM EDT
Allakos Market Cap
Revelation Biosciences has a market cap or net worth of $3.65 million as of August 8, 2025. Its market cap has increased by 38.93% in one year.
Market Cap
3.65M
Enterprise Value
-1.52M
1-Year Change
38.93%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $3.65M, a decrease of -95.96%. That is a compound annual growth rate of -49.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 3.91M | 1.58% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | 93.20M | 2.97% |
| Nov 17, 2020 | 90.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |